FR09C0047I2 - PREPARATION OF IMMUNOGENIC RECOMBINATION PRODUCTS USING SOLUBLE CARBONHYDRATES ACTIVATED THROUGH ORGANIC CYANYLATION REAGENTS - Google Patents

PREPARATION OF IMMUNOGENIC RECOMBINATION PRODUCTS USING SOLUBLE CARBONHYDRATES ACTIVATED THROUGH ORGANIC CYANYLATION REAGENTS

Info

Publication number
FR09C0047I2
FR09C0047I2 FR09C0047C FR09C0047C FR09C0047I2 FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2 FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2
Authority
FR
France
Prior art keywords
carbonhydrates
immunogenic
soluble
activated
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0047C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Found For T
Original Assignee
Henry M Jackson Found For T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/408,717 external-priority patent/US5651971A/en
Priority claimed from PCT/US1996/004013 external-priority patent/WO1996029094A1/en
Publication of FR09C0047I1 publication Critical patent/FR09C0047I1/fr
Application filed by Henry M Jackson Found For T filed Critical Henry M Jackson Found For T
Application granted granted Critical
Publication of FR09C0047I2 publication Critical patent/FR09C0047I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
FR09C0047C 1995-03-22 2009-09-24 PREPARATION OF IMMUNOGENIC RECOMBINATION PRODUCTS USING SOLUBLE CARBONHYDRATES ACTIVATED THROUGH ORGANIC CYANYLATION REAGENTS Active FR09C0047I2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/408,717 US5651971A (en) 1993-09-22 1995-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US48266195A 1995-06-07 1995-06-07
PCT/US1996/004013 WO1996029094A1 (en) 1995-03-22 1996-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents

Publications (2)

Publication Number Publication Date
FR09C0047I1 FR09C0047I1 (en) 2009-06-11
FR09C0047I2 true FR09C0047I2 (en) 2017-03-17

Family

ID=41360971

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0047C Active FR09C0047I2 (en) 1995-03-22 2009-09-24 PREPARATION OF IMMUNOGENIC RECOMBINATION PRODUCTS USING SOLUBLE CARBONHYDRATES ACTIVATED THROUGH ORGANIC CYANYLATION REAGENTS

Country Status (5)

Country Link
JP (1) JP5594612B2 (en)
KR (1) KR100417183B1 (en)
DE (2) DE122009000056I1 (en)
FR (1) FR09C0047I2 (en)
NL (2) NL300413I1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5892944B2 (en) * 2009-12-17 2016-03-23 フィナ バイオソリューションズ リミテッド ライアビリティ カンパニー Chemical reagents for the activation of polysaccharides in the manufacture of conjugate vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343210B (en) * 1967-12-20 1972-03-06 Pharmacia Ab
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
DE3541186A1 (en) * 1985-11-21 1987-05-27 Boehringer Mannheim Gmbh WATER-SOLUBLE, STABILIZED PEROXIDASE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USE FOR DETERMINING HYDROGEN PEROXIDE
NZ236050A (en) * 1989-11-15 1993-04-28 Sandoz Ltd Water soluble conjugate of a polymyxin and a carrier
EP0630260B1 (en) * 1991-03-12 2001-01-24 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Polysaccharide-protein conjugates
EP1958646A1 (en) * 1992-02-11 2008-08-20 Henry M. Jackson Foundation For The Advancement Of Military Medicine Dual carrier immunogenic construct
WO1994013697A1 (en) * 1992-12-07 1994-06-23 Magainin Pharmaceuticals, Inc. Treatment of septic shock with conjugated biologically active peptides

Also Published As

Publication number Publication date
DE122009000056I1 (en) 2010-01-28
KR19980703201A (en) 1998-10-15
JP5594612B2 (en) 2014-09-24
JP2012116850A (en) 2012-06-21
NL300414I1 (en) 2009-12-01
DE122009000055I1 (en) 2009-12-31
NL300413I1 (en) 2009-12-01
KR100417183B1 (en) 2004-05-31
FR09C0047I1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
IL113817A0 (en) Polynucleotide vaccine for papillomavirus pharmaceutical compositions containing it and a method for its use
LU92153I2 (en) Teduglutide in all its forms as protected by the basic patent
EP0372466A3 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
AU4741997A (en) Oral administration of chicken yolk antibodies to treat disease
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
FR09C0047I2 (en) PREPARATION OF IMMUNOGENIC RECOMBINATION PRODUCTS USING SOLUBLE CARBONHYDRATES ACTIVATED THROUGH ORGANIC CYANYLATION REAGENTS
HUP0002724A3 (en) Clasto-lactacystin betha-lactone, analogs and intermediates thereof, process for their preparation and pharmaceutical compositions containing them
AU5992198A (en) Novel arylpiperazine derived from piperidine as antidepressant medicines
EE200000129A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ol, process for their preparation and use as pharmaceuticals
FR2645878B1 (en) NUCLEOTIDE SEQUENCES OF ACTINOMYCETALS, APPLICATIONS FOR THE SYNTHESIS OR DETECTION OF NUCLEIC ACIDS, EXPRESSION PRODUCTS OF SUCH SEQUENCES AND APPLICATION AS IMMUNOGENIC COMPOSITIONS
IT1291255B1 (en) DEVICE FOR STACKING GROUPS OF SELECTED PRODUCTS TO BE PACKING.
DK0760394T3 (en) Mild Newcastle disease virus vaccine
NO981070D0 (en) Benzothiopheners-2-carboxamides-S, S-dioxides used to prevent fouling
CO4910113A1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS, BASED ON QUINU- PRISTINE AND DALPHOPRISTINE AND THEIR PREPARATION
FR2731355B1 (en) NOVEL IMMUNOGENS, NOVEL ANTIBODIES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU630186B2 (en) Canine corona virus vaccine
IT1276509B1 (en) VACCINE FOR THE IMMUNE PROPHYLAXY OF FELINE IMMUNODEFICIENCY VIRUS INFECTION OF DOMESTIC CAT.
FR2583049B1 (en) PRODUCTS RESULTING FROM THE CONJUGATION OF A MACROMOLECULAR SUPPORT, A HAPTENA AND A MURAMYL-PEPTIDE THROUGH A GROUP SUBSTITUTING THE SACCHARIDIC PART OF MURAMYL-PEPTIDE AND SELECTIVELY IMMUNOGENIC COMPOSITIONS CONTAINING THESE PRODUCTS
RU97120940A (en) PEPTIDE OWNED BY IMMUNOMODULATING ACTIVITY AND A DRUG ON ITS BASIS
ATE42743T1 (en) THIOCHROMAN DERIVATIVE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT.
TR199600434A1 (en) Conversion of substituted 8-chloroquinolines to substituted 8-hydrocyquinolines.
DE69614552D1 (en) MODIFIED ALPHA-D-GLCP- (1,2) -ALPHA-D-Glcp- (1,3) -ALPHA-D-Glcp ANALOGS
ITBO970728A0 (en) METHOD FOR THE APPLICATION OF TIES TO PACKAGES SUBSTANTIALLY LIKE EPIPEDS.
FR2665834B1 (en) PHARMACEUTICAL COMPOSITION STABILIZED BY A DONOR OF HYDROCHLORIC ACID, AND ITS PREPARATION.